跳至主要内容
临床试验/IRCT20210212050334N2
IRCT20210212050334N2尚未招募1 期

Evaluation of safety and efficacy of stromal vascular fraction on foot diabetic wound-clinical trial phase I and II

Rasht University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Having chronic outpatient diabetic foot ulcer
  • Age range from 30 to 60 years
  • Having a single wound on the foot and limb terminals (fingers, sole, heel, toes) within four works without repair
  • Body Mass index 18-25
  • ABI / TBI ratio greater than 0.9.

排除标准

  • Alcohol consumption
  • Drug addiction
  • Taking drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents.
  • A concomitant disease that may interfere with wound healing, such as cancer, vasculitis, kidney, liver, or heart failure.
  • Osteomyelitis

研究者

发起方
Rasht University of Medical Sciences

相似试验